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Abstract
Background: Single nucleotide polymorphisms (SNPs) in the genes encoding the vitamin D receptor (VDR) and the
vitamin D binding protein (DBP) have been reported to modify the influence of vitamin D deficiency on susceptibility
to active tuberculosis (TB) in the UK, but this phenomenon has not been investigated in settings with a high TB
burden. SNPs in CYP2R1, which encodes a vitamin D 25-hydroxylase enzyme, are known to influence vitamin D status,
but their potential role in determining susceptibility to TB has not previously been investigated in any setting.
Method: We conducted a case–control study in 260 pulmonary TB patients and 112 controls recruited in Lahore,
Pakistan. Analyses were conducted to test for main effects of vitamin D status and SNPs in VDR (rs731236, rs2228570
and rs1544410), DBP (rs7041 and rs4588) and CYP2R1 (rs2060793, rs10500804 and rs10766197) on susceptibility to TB,
and to investigate whether these SNPs modify the association between vitamin D status and disease susceptibility.
Results: Profound vitamin D deficiency (serum 25-hydroxyvitamin D concentration≤ 20 nmol/L) was common among
TB patients (118/260, 45 %), and was independently associated with susceptibility to TB (adjusted odds ratio 1.87, 95 %
CI 1.15 to 3.04, P = 0.01). However, none of the SNPs investigated associated with susceptibility to TB, either in main
effects analysis, or in interaction with vitamin D status.
Conclusion: Profound vitamin D deficiency was common among TB patients in this high-burden setting, and was
independently associated with disease susceptibility. However, no statistically significant associations between SNPs in
the vitamin D pathway and disease susceptibility was demonstrated.
Keywords: Tuberculosis, Vitamin D, Vitamin D Receptor, Hypovitaminosis D, Vitamin D binding protein, Vitamin D
25-hydroxylase
Background
Tuberculosis (TB) is a leading global cause of morbidity
and mortality, responsible for an estimated 1.5 million
deaths in 2014 [1]. The identification of factors which
increase disease susceptibility has potential to inform
control strategies. Case control studies have previously
reported independent associations between vitamin D
deficiency and susceptibility to active TB [2]. However,
interpretation of such studies is limited by their cross-
sectional nature, as they cannot determine whether vita-
min D deficiency is a cause or a consequence of active
TB. The case for vitamin D deficiency playing a causal
role in enhancing disease susceptibility is supported by
findings of genetic studies reporting that polymorphisms
in the vitamin D receptor (VDR) and the vitamin D
binding protein (DBP) genes modify the influence of
vitamin D status on susceptibility to active disease in the
UK [3, 4]. Only one study is present who have investi-
gated such gene-environment interactions; analogous in-
vestigations in high TB burden countries are therefore
needed [5]. Moreover, no study has previously investi-
gated whether polymorphisms in the gene encoding the
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vitamin D hydroxylase enzyme, CYP2R1, are associated
with susceptibility to TB, either as a main effect, or
as a modifier of the effects of vitamin D status. This
gene is a plausible candidate for effect modification,
as 25-hydroxylation of ‘parent’ vitamin D3 (cholecaciferol,
synthesized in the skin on exposure to ultra-violet B
radiation) to form the major circulating vitamin D me-
tabolite 25-hydroxyvitamin D (25[OH]D) is a key de-
terminant of circulating 25(OH)D concentrations [6].
We therefore conducted a case–control study to de-
termine the influence of vitamin D status and single
nucleotide polymorphisms (SNPs) in VDR, DBP and
CYP2R1 on susceptibility to active TB in Pakistan, a
high-burden setting where TB incidence in 2014 was
estimated at 270 cases per 100,000 population per
year [1]. Having demonstrated an independent associ-
ation between vitamin D deficiency and susceptibility
to active TB in the study population, we proceeded to
investigate whether this was modified by SNPs in the
vitamin D pathway.
Methods
Study design
We conducted a case control study. Cases were patients
aged 14–60 years with newly-diagnosed smear-positive
pulmonary TB, recruited from the Gulab Devi Chest
hospital, Lahore. Patients with any of the following
conditions documented in the hospital record were
excluded: diabetes mellitus, ischemic heart disease,
chronic renal failure, jaundice or seropositivity for
hepatitis B surface antigen, Hepatitis C Virus or Hu-
man Immunodeficiency Virus. Controls were healthy
relatives of TB patients or hospital staff working at the
same hospital with no history of previous tuberculosis
but exposed to TB cases. Participants who fulfilled eli-
gibility criteria were asked to complete a questionnaire
detailing their age, gender and monthly income. In-
formed consent was taken from all participants before
sample collection. The study was approved from the
ethical committee of the University of Punjab (Ref
No: SBS 873–12) and also from Gulab Devi Chest
Hospital, Lahore.
Five mL of blood were drawn from a median cubital
vein; 2 mL were transferred into vials containing EDTA
and frozen at −20 °C for subsequent DNA extraction,
and 3 mL were added to serum vials and sent to the la-
boratory within two hours of collection, where serum
was isolated from clotted blood by centrifugation and
stored at −20 °C for subsequent determination of
25(OH)D concentration.
Serum 25 (OH)D assay
Serum 25(OH)D concentration was determined by ELISA
(Immunodiagnostic Systems, Boldon,UK). Calibrators
and controls provided with kits were run in duplicate.
For the purpose of this study, a patient with 25(OH)
vitamin D level equal or less than 20 nmol/L was
considered to be vitamin D deficient. Inter-assay CV for
serum 25(OH)D assay for our samples was 12.5 %.
Genotyping
Genomic DNA was extracted from whole blood and
quantified using a nanodrop spectrophotometer as
previously described [7]. TaqMan allelic probe assays
(Applied Biosystems, Foster City, CA, USA) were
used to genotype polymorphisms in genes encoding
the vitamin D receptor VDR [(rs731236 Taq I), (rs2228570
Bsm I); (rs1544410 Fok I)]; the vitamin D 25-hydroxylase
CYP2R1 [(rs2060793, rs10500804, rs10766197)] and the
vitamin D binding protein DBP [(rs7041) and (rs4588)].
All primers were commercially prepared. Details of
primers used in this study has been provided in
Additional file 1. The PCR reaction mixture contained
7.5 μL of TaqMan Genotyping master mixture,
0.75 μL of TaqMan SNP (probes), 1 μL of genomic
DNA (1–10 ng), and 5.75 μL nuclease free water.
Thermal conditions were as follows: initial denaturation
at 95 °C for 10 min, 40 cycles were run at 95 °C for
15 seconds (denaturing) followed by 60 °C for 1 min
(annealing/extension). PCR plates were read by 7900HT
seq detection system ABI prism.
Sample size and statistical analysis
Sample size was calculated using OpenEpi sample
calculator [8] assuming an expected frequency of 57 %
vitamin D deficiency in cases and 33 % in controls [9].
Statistical analyses were done with SPSS version 20. Chi
square tests were used for univariate analyses exploring
potential determinants of vitamin D status and suscep-
tibility to active TB, and binary logistic regression ana-
lysis was used for corresponding multivariate analyses.
Sub-group analyses were performed to determine
whether genetic variation in the vitamin D pathway
modified effects of vitamin D status on susceptibility to
active TB by repeating primary efficacy analyses with
the inclusion of a term for an interaction between vita-
min D status and genotype. Odds ratios are presented
with 95 % confidence intervals and P-values.
Results
Participant characteristics
A total of 260 cases with smear-positive pulmonary TB
and 112 controls were recruited to the study between
August 2012 and September 2013. The mean age of
cases and controls was 31.6 years (s.d. 10.5 years, range
14–55 years) vs. 30.6 years (s.d. 9.3, range 15–56 years)
respectively. Fifty-four percent of cases and 48 % of
controls were female. Forty-five percent of cases and
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30 % of controls had profound vitamin D deficiency
(serum 25[OH]D ≤20 nmol/L), and mean serum
25(OH)D concentration was lower in cases vs. controls
(27.3 vs. 43.3 nmol/L respectively, 95 % CI for differ-
ence 11.5–22.8, P < 0.0001; Fig. 1).
Determinants of vitamin D status in cases and controls
Table 1 presents determinants of vitamin D status in
cases and controls. Vitamin D deficiency was inde-
pendently associated with female vs. male gender
(aOR 2.31, 95 % CI 1.33 to 4.01, P = 0.003; aOR 3.67,
95 % CI 1.38 to 9.70, P = 0.01) and sampling in
October-March vs. April-September (aOR 1.89, 95 %
CI 1.14 to 3.16, P = 0.01; aOR 2.55, 95 % CI 1.03 to
6.31, P = 0.04) in both case and control populations,
respectively (Table 1).
Association between phenotypic features and
susceptibility to active tuberculosis
Table 2 presents results of univariate and multivariate
analyses testing for associations between participants’
phenotypic features and susceptibility to active TB.
Active TB was independently associated with lower
monthly income (aOR 1.68, 95 % CI 1.06 to 2.66, P = 0.02)
and presence of profound vitamin D deficiency (aOR 1.87,
95 % CI 1.15 to 3.04, P = 0.01). The following phenotypic
features were not found to associate with susceptibil-
ity to active TB: age, sex, marital status or season of
recruitment.
Association between vitamin D pathway genotype and
susceptibility to active tuberculosis
Table 3 presents results of analyses testing for associa-
tions between genetic variation in VDR, CYP2R1 and
DBP and susceptibility to active TB, adjusting for
monthly income and vitamin D status. No statistically
significant association was observed between suscepti-
bility to active TB and any polymorphism investigated.
Association between vitamin D deficiency and host
genotype, stratified by vitamin D status
We next proceeded to investigate whether genetic vari-
ation in VDR, DBP or CYP2R1 modified the association
between vitamin D deficiency and susceptibility re-
ported above. Results of the pertinent sub-group and
interaction analyses are presented in Table 4: these
revealed no evidence to support the hypothesis that
polymorphisms in the vitamin D pathway modify the
effect of vitamin D deficiency on risk of active TB.
Discussion
We report that vitamin D deficiency is very common
among TB patients in Pakistan, and that it associates
Table 1 Determinants of vitamin D status in TB cases and controls
TB cases Control
Characteristics 25 (OH) D ≤20 nmol/l aOR(95 % CI)a P 25(OH) D ≤20 nmol/l aOR(95 % CI)a P
Age >30 years 56/124 (45 %) Ref 17/50 (34 %) Ref
≤30 years 62/136 (46 %) 1.26(0.71-2.32) 0.44 17/62 (27 %) 1.46(0.60-3.56) 0.40
Sex Male 43/120 (36 %) Ref - 11/58 (19 %) Ref -
Female 75/140 (54 %) 2.31(1.33-4.01) 0.003 23/54 (43 %) 3.67(1.38-9.70) 0.01
Marital status Single 49/114 (43 %) Ref - 16/54 (30 %) Ref -
Married 69/146 (46 %) 1.34(0.71-2.55) 0.36 18/58 (31 %) 1.63(0.64-1.43) 0.30
Monthly income, PKR <10,000 84/177 (47 %) 1.27(0.73-2.20) 0.38 18/62 (29 %) 1.0(0.42-2.40) 0.98
≥10,000 34/83 (41 %) Ref - 16/50 (32 %) Ref -
Month of recruitment April-September 53/137 (39 %) Ref - 10/53 (19 %) Ref -
October-March 65/123 (53 %) 1.89(1.14-3.16) 0.01 24/59 (41 %) 2.55(1.03-6.31) 0.04
aOdds ratio adjusted for age, sex, marital status, monthly income and month of recruitment. PKR Pakistani rupees, 25(OH)D, 25-hydroxyvitamin D
Fig. 1 Serum 25-hydroxyvitamin D (25[OH]D) concentrations in TB
cases (n = 260) and healthy controls (n = 112). P value from unpaired
t test comparison of means
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independently with susceptibility to active TB. Risk of
deficiency was independently associated with sampling
in January - March and with female gender in cases
and controls alike. However, we found no evidence to
suggest that polymorphisms in CYP2R1, VDR or DBP
influenced susceptibility to TB in this population,
either as main effects, or in interaction with vitamin
D deficiency.
Our finding of an independent association between
vitamin D deficiency and susceptibility to active TB is in
keeping with previous reports from Pakistan [9] and
elsewhere [10]. A prospective study in Pakistan has
previously reported that vitamin D deficiency precedes
onset of active disease [11], and laboratory studies have
reported that vitamin D metabolites induce antimyco-
bacterial activity in vitro [12]: taken together, such re-
ports suggest that vitamin D deficiency plays a causal
role in increasing susceptibility to active TB. However,
cross-sectional studies such as our own cannot distin-
guish causality from reverse causality, and the possibility
remains that active TB may be a cause, as well as a
consequence, of vitamin D deficiency.
Table 3 Association between vitamin D pathway genotype and susceptibility to active tuberculosis
SNP, gene Genotype TB cases, n/N (%) TB contacts, n/N (%) aOR (95 % CI)a P
rs7312236, VDR AA 84/230 (37 %) 42/100 (42 %) Ref -
AG/GG 146/230 (63 %) 58/100 (58 %) 1.22(0.75-1.98) 0.42
rs154410, VDR CC 53/235 (23 %) 29/106 (27 %) Ref -
CT/TT 182/235 (77 %) 77/106 (73 %) 1.23(0.71-2.09) 0.45
rs228570, VDR GG 137/235 (59 %) 68/107 (64 %) Ref -
GA/AA 98/235 (41 %) 39/107 (36 %) 1.89(0.80-2.10) 0.28
rs7041, DBP AA 55/232 (24 %) 21/102 (21 %) Ref -
AC/CC 177/232 (76 %) 81/102 (79 %) 0.77(0.43-1.39) 0.39
rs4588, DBP GG 122/234 (52 %) 50/107 (47 %) Ref -
GT/TT 112/234 (48 %) 57/107 (53 %) 0.93(0.58-1.49) 0.77
rs10500804, CYP2R1 GG 59/231 (26 %) 22/103 (22 %) Ref -
GT/TT 172/231 (74 %) 81/103 (78 %) 0.83(0.47-1.47) 0.53
rs2060793, CYP2R1 GG 112/228 (49 %) 51/101 (50 %) Ref -
AG/AA 116/228 (51 %) 50/101 (50 %) 0.91(0.56-1.48) 0.72
rs10766197, CYP2R1 AA 52/232 (23 %) 19/104 (18 %) Ref -
AG/GG 124/232 (77 %) 55/104 (82 %) 0.68(0.37-1.26) 0.23
aOdds ratio adjusted for monthly income and vitamin D status, SNP single nucleotide polymorphism, Ref Referent category, VDR Vitamin D receptor, CYP2R1 Vitamin D
25-hydroxylase, DBP Vitamin D binding protein. The total number of samples is less than 260 and 112 in cases and controls respectively due to failed genotyping for
some samples
Table 2 Association between participants phenotypic characteristics and susceptibility to active tuberculosis
TB cases (N = 260) Control (N = 112) OR (95 % CI) P aOR(95 % CI)a P
Age >30 years 124 (48 %) 50 (45 %) Ref - Ref -
≤30 years 136 (52 %) 62 (55 %) 1.01(0.58-1.42) 0.68 1.01(0.61-1.68) 0.94
Sex Male 120 (46 %) 58 (52 %) Ref - Ref -
Female 140 (54 %) 54 (48 %) 1.25(0.80-1.95) 0.31 1.06(0.65-1.75) 0.79
Marital status Single 114 (44 %) 54 (48 %) Ref - Ref -
Married 146 (56 %) 58 (52 %) 1.19(0.76-1.86) 0.43 1.13(0.67-1.90) 0.63
Monthly income, PKR <10,000 177 (68 %) 62 (55 %) 1.72(1.10-2.71) 0.02 1.68(1.06-2.66) 0.02
≥10,000 83 (32 %) 50 (45 %) Ref - Ref -
Season of recruitment April-September 137 (53 %) 53 (47 %) 1.24(0.79-1.23) 0.34 1.24(0.78-1.96) 0.34
October-March 123 (47 %) 59 (53 %) Ref - Ref -
Serum 25(OH)D, nmol/L ≤20 nmol/L 118 (45 %) 34 (30 %) 1.90(1.19-3.05) 0.02 1.87(1.15-3.04) 0.01
>20 nmol/L 142(55 %) 78(70 %) Ref - Ref -
aOdds ratio adjusted for age, sex, marital status, monthly income, season of recruitment and serum 25(OH)D concentration. PKR, Pakistani rupees; 25(OH)D,
25-hydroxyvitamin D
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Table 4 Association between vitamin D deficiency and host genotype, stratified by vitamin D status
SNP, gene Genotype Serum 25(OH) D ≤20 nmol/l Serum 25(OH) D >20 nmol/l
TB cases Controls OR(95 % CI) P TB cases Control OR(95 % CI) P Adjusted ratio of odds ratiosa P interaction
rs7312236, VDR AA 30/102(29 %) 12/24(50 %) Ref - 54/128(42 %) 30/76(40 %) Ref - Ref -
AG/GG 72/102(71 %) 12/24(50 %) 2.40(0.96-5.94) 0.054 74/128(58 %) 46/76(60 %) 0.89(0.50-1.59) 0.70 1.65(0.59-4.58) 0.33
rs154410, VDR CC 16/105(15 %) 8/25(32 %) Ref - 37/130(29 %) 21/81(26 %) Ref Ref -
CT/TT 89/105(85 %) 17/25(68 %) 2.61(0.96-7.07) 0.052 93/130(71 %) 60/81(74 %) 0.88(0.47-1.64) 0.68 2.16(0.69-6.75) 0.18
rs228570, VDR GG 60/105(57 %) 13/25(52 %) Ref - 77/130(59 %) 55/82(67 %) Ref Ref -
GA/AA 45/105(43 %) 12/25(48 %) 0.81(0.33-1.94) 0.64 53/130(41 %) 27/82(33 %) 1.40(0.78-2.5) 0.25 0.48(0.17-1.29) 0.14
rs10500804, CYP2R1 GG 27/102(26 %) 6/23(26 %) Ref - 32/129(25 %) 16/80(20 %) Ref Ref -
GT/TT 75/102(74 %) 17/23(74 %) 0.98(0.35-2.74) 0.97 97/129(75 %) 64/80(80 %) 0.75(0.38-1.49) 0.42 1.51(0.47-4.8) 0.48
rs2060793, CYP2R1 GG 48/104(46 %) 11/22(50 %) Ref - 64/124(52 %) 40/79(51 %) Ref Ref -
AG/AA 56/104(54 %) 11/22(50 %) 1.16(0.46-2.92) 0.74 60/124(48 %) 39/79(49 %) 0.96(0.54-1.69) 0.89 1.02(0.37-2.78) 0.96
rs10766197, CYP2R1 AA 23/104(22 %) 4/23(17 %) Ref - 29/128(23 %) 15/81(19 %) Ref Ref -
AG/GG 81/104(78 %) 19/23(83 %) 0.74(0.22-2.39) 0.60 99/128(77 %) 66/81(81 %) 0.77(0.38-1.55) 0.47 1.25(0.35-4.45) 0.72
rs7041, DBP AA 27/104(52 %) 4/23(43.5 %) Ref - 26/133(20 %) 19/74(47 %) Ref Ref -
AC/CC 77/10(35 %) 19/23(43.5 %) 0.60(0.18-1.9) 0.39 107/133(80 %) 55/74(45 %) 1.42(0.72-2.79) 0.30 1.15(0.34-3.88) 0.81
rs4588, DBP GG 55/105(52 %) 10/24(42 %) Ref - 68/135(50 %) 38/76(50 %) Ref - Ref -
GT/TT 50/105(48 %) 14/24(58 %) 0.64(0.26-1.59) 0.34 67/135(50 %) 38/76(50 %) 0.98(0.56-1.72) 0.95 0.93(0.35-2.48) 0.89
aAdjusted for monthly income and vitamin D status, SNP single nucleotide polymorphism, Ref Referent category; VDR, Vitamin D receptor; CYP2R1, Vitamin D 25-hydroxylase; DBP, Vitamin D binding protein. The total
number of samples is less than 260 and 112 in cases and controls respectively due to failed genotyping for some samples
Junaid
et
al.BM
C
Pulm
onary
M
edicine
 (2016) 16:73 
Page
5
of
6
By contrast, our study did not replicate previous re-
ports of associations between polymorphisms in VDR
and DBP and susceptibility to active TB [4, 13], either as
main effects or in interaction with serum 25(OH)D con-
centration. Neither did we find any such associations for
variants in CYP2R1. “A recent study in pulmonary TB in
a cohort of HIV-infected and HIV exposed uninfected
children in South Africa also showed no association
between polymorphisms in VDR, DBP and CYP2R1
and a diagnosis of TB [5]. It should be noted, how-
ever, that our study was formally powered to detect
associations between vitamin D deficiency and suscep-
tibility to active tuberculosis, rather than genetic associa-
tions: the strength of previously reported associations
is modest, and we may have lacked power to detect
weaker associations. Another limitation of this study
is that we collected information on a limited set of
confounders. Despite adjustment for these, we cannot
exclude the possibility that residual confounding may
have contributed to the association seen.
Women participants in this study had lower vitamin
D status that was in keeping with our previous re-
ports that female gender is a risk factor for vitamin
D deficiency; women may experiencing less sun ex-
posure than men, and may also have lower dietary
vitamin D intake [14, 15].
Conclusion
In conclusion, our study reports an independent asso-
ciation between vitamin D deficiency and susceptibil-
ity to active tuberculosis in Pakistani adults. However,
polymorphisms in VDR, DBP and CYP2R1 were not found
to associate with susceptibility to disease in this setting.
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